Fresh analysis indicates that individuals who come off popular weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who halt conventional diet and exercise plans.
Findings released in a leading medical journal points out that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"People using such medications need to be aware of the danger of rapid rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to starting mass within about one and a half years.
Comparing Therapies
The research, which reviewed dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
Researchers note that people who lose weight through lifestyle changes alone generally see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Nutrition scientists believe the mechanism of the injections accounts for the accelerated rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making excessive eating far more likely."
A Chronic Condition?
Health authorities recommend the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts argue that, due to the likelihood of relapse, the therapy should be considered ongoing.
This view is echoed by drug manufacturers, who state that the findings "underscore the long-term nature of excess weight," similar to managing diseases like diabetes.
Patient Accounts
People who have come off the jabs describe a powerful return of appetite.
"It felt as if a switch flipping and you become extremely hungry," described one woman.
The struggle is worsened if users have not established permanent lifestyle or habit modifications during treatment.
Growing Adoption
Survey data suggest that a significant number of people in the UK have tried these injections in the past year, with desire remaining high.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Ultimately, experts caution that while the jabs are powerful tools for weight loss, they are not a permanent solution and lasting health benefits relies on integrated behavioural management.
